Search This Blog

Tuesday, December 12, 2023

Intra-Cellular Therapies gains amid repeated takeover speculation

Intra-Cellular Therapies (ITCI) rises as takeover speculation continues, with JPMorgan and Centerview possibly involved.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)